Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of depo-provera® to women
- 1 October 1976
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 14 (4), 461-469
- https://doi.org/10.1016/s0010-7824(76)80060-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginallyContraception, 1976
- The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkeyContraception, 1976
- Injectable long-acting progestogen contraception: A neglected modalityAmerican Journal of Obstetrics and Gynecology, 1974
- Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera)Contraception, 1974
- Contraceptive Use—Efficacy Study Utilizing Medroxyprogesterone Acetate Administered As An Intramuscular Injection Once Every 90 DaysFertility and Sterility, 1973
- Experience with Depo-Medroxyprogesterone Acetate (Depo-Provera) as a Contraceptive AgentPublished by Wiley ,1972
- Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1Journal of Clinical Endocrinology & Metabolism, 1971
- Effects of depo-medroxyprogesterone acetate as a contraceptive agentAmerican Journal of Obstetrics and Gynecology, 1971
- Present Status of Injectable Contraceptives: Results of Seven-Years StudyFertility and Sterility, 1970
- Effect of 6α-methyl-17α-hydroxyprogesterone on urinary excretion of luteinizing hormoneAmerican Journal of Obstetrics and Gynecology, 1967